SAINT PAUL, Minn. (March 16, 2010) — Angeion Corporation (NASDAQ: ANGN), today announced its intention to repurchase up to $1,000,000 worth of its outstanding shares in the open market or in privately negotiated transactions.  These shares will be purchased from time-to-time over a nine-month period. The timing and actual number of shares purchased will depend upon a variety of factors, such as price, corporate and regulatory requirements, alternative investment opportunities, and other market and economic conditions.  Repurchases under the program will be funded from available working capital.  The program may be commenced, suspended or terminated at any time, or from time-to-time at management’s discretion without prior notice.

Rodney A. Young, Angeion’s President and Chief Executive Officer, indicated that the Company’s board of directors approved the repurchase program in view of the current price level of Angeion’s common stock and its strong capital position.

Said Young, “We believe that the repurchase of our shares represents an attractive investment opportunity which will benefit the company and our shareholders. We also believe that we can continue to invest in the initiatives that are key to our future success.”

As of January 31, 2010 Angeion had 4,157,066 shares outstanding and shareholders’ equity of $16.0 million.    

About Angeion Corporation
Founded in 1986, Angeion Corporation acquired Medical Graphics Corporation in December 1999. Medical Graphics develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics (www.medgraphics.com) and New Leaf (www.newleaffitness.com) brand and trade names. These cardiorespiratory diagnostic systems have a wide range of applications in healthcare as well as health and fitness. The Company’s products are sold internationally through distributors and in the United States through a direct sales force that targets heart and lung specialists located in hospitals, university-based medical centers, medical clinics and physicians’ offices, pharmaceutical companies, medical device manufacturers, clinical research organizations, health and fitness clubs, personal training studios, and other exercise facilities. For more information about Angeion, visit www.angeion.com.

###